Brief: Sellas Life Sciences Provides Business Update And Reports Q3 Financial Results
14/11/2022 18:20
Nov 14 (Reuters) - Sellas Life Sciences Group Inc
SLS.O :
* SELLAS LIFE SCIENCES PROVIDES BUSINESS UPDATE AND REPORTS
THIRD
QUARTER 2022 FINANCIAL RESULTS
* SELLAS LIFE SCIENCES GROUP INC - AS OF SEPTEMBER 30, 2022,
CASH
AND CASH EQUIVALENTS TOTALED APPROXIMATELY $21.3 MILLION
* SELLAS LIFE SCIENCES GROUP INC - QTRLY LOSS PER SHARE OF
$0.34
Source text for Eikon: ID:nGNXCC8bw
Further company coverage: SLS.O
Recent news on Sellas Life Sciences
See all newsBrief: Sellas Life Sciences Reaches 80Th Event In Phase 3 Regal Trial Of Galinpepimut-S (Gps) In Acute Myeloid Leukemia
SELLAS Life Sciences Q2 net loss widens on higher expenses
Brief: SELLAS Life Sciences Q2 Net Income USD -9.605 Million
Arbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
SELLAS Life Sciences Q1 net loss widens on higher expenses